Abstracto
Stent length as a potential indicator to select patients who may benefit from long-term dual antiplatelet therapy
G Schurtz, A Manchuelle & G Lemesle“There is to date sufficient data to show us that a 1-year DAPT is not necessarily the best regimen for all CAD patients and that a tailored approach might be warranted.”
Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.